You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

VOLTAREN-XR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Voltaren-xr patents expire, and when can generic versions of Voltaren-xr launch?

Voltaren-xr is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in VOLTAREN-XR is diclofenac sodium. There are forty-seven drug master file entries for this compound. One hundred and twenty-nine suppliers are listed for this compound. Additional details are available on the diclofenac sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Voltaren-xr

A generic version of VOLTAREN-XR was approved as diclofenac sodium by ACTAVIS ELIZABETH on March 26th, 1996.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for VOLTAREN-XR?
  • What are the global sales for VOLTAREN-XR?
  • What is Average Wholesale Price for VOLTAREN-XR?
Summary for VOLTAREN-XR
Drug patent expirations by year for VOLTAREN-XR
Recent Clinical Trials for VOLTAREN-XR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Washington State UniversityEarly Phase 1
University of RijekaN/A
German University in CairoPhase 2

See all VOLTAREN-XR clinical trials

US Patents and Regulatory Information for VOLTAREN-XR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis VOLTAREN-XR diclofenac sodium TABLET, EXTENDED RELEASE;ORAL 020254-001 Mar 8, 1996 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.